PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding
PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding Size and Share Published in 2014-03-12 Available for US$ 2995 at Researchmoz.us
Description
GlobalDatas \"PharmaSphere: Emerging Biotech Investment Report Strategic Trends in Private Equity and Venture Capital Funding\" report provides in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry, bearing in mind that these are expected to have significant impact on the future of emerging biotechnology companies in the US and globally. Furthermore, the report identifies regions of the world that are attracting more investments in healthcare and discusses the various factors responsible for this trend. In addition, the report provides detailed profiles of 12 leading private equity firms, 15 top venture capital firms, and 15 US-based emerging biotechnology companies that completed initial public offerings in 2013.
Throughout the report, GlobalDatas analysts provide you with expert insight, expanding on each observation, strategy, and trend discussed, with the aim of providing you with the tools needed for making informed business decisions in the rapidly changing global investment landscape.
Highlights
Key Questions Answered
What are the current trends impacting emerging biotechnology investment in the US and globally?
What regions are witnessing noteworthy investment in healthcare and what are the factors driving such occurrences?
What therapeutic areas are attracting the most investment by private equity and venture capital firms and why?
What has been the trend of equity offerings in the healthcare sector since 2004 and what factors were responsible?
What is the strategic outlook of emerging biotechnology investment?
About the Report
This report is an essential source of information and analysis on emerging biotech investment, with significant emphasis on the US. GlobalData provides an in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry. The report highlights the various therapeutic areas attracting noteworthy funding in terms of the volume and value of new and follow-on investments and discusses the factors responsible for this trend. Furthermore, it provides a strategic outlook on future trends that are expected in private equity and venture capital funding and how they will impact the growth and development of biotech companies globally.
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=191348
Scope
Historical trend analysis of private equity and venture capital funding prior toand after the financial market crash of 2008, including a change in the average value of completed deals in the healthcare industry
The report highlights how ongoing healthcare reform in parts of Europe and North America are resulting in a shift of deals activity involving private equity and venture capital firms to the Asia-Pacific
Discussion of therapeutic areas attracting significant investments, as well as the factors responsible for such trends
Detailed profiles of 12 leading private equity firms, 15 top venture capital firms, and 15 US-based emerging biotechnology companies that completed initial public offerings in 2013
Global strategic outlook on future trends that are expected in private equity and venture capital funding, as well as the need for a new financing model to drive the sustainable growth of emerging biotech companies.
Reasons to buy
Understand the current trends impacting emerging biotechnology investment in the US and globally
Evaluate the strategies being used by leading private equity and venture capital firms as they aim to minimize risk and ensure significant return on investment
Gain valuable insights into the investment strategies, deals, and portfolios of leading private equity and venture capital firms
Gain valuable insights into US-based, innovative emerging biotechnology companies with venture capital backing, their developmental pipelines, and strategic collaborations
Use this information as an independent source for your due diligence and transaction strategy
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=191348
Table of Content
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 15
2 Introduction 18
2.1 Report Scope 18
2.2 Upcoming Related Reports 19
2.3 Recently Published Reports 19
3 US Private Equity and Venture Capital Industry Dynamics 21
3.1 Post-2008 Financial Market Crash: Volume of Capital Commitments to Private Equity Funds Show Signs of Recovery 21
3.1.1 Venture Capital Fundraising Trend in the US 22
3.2 Volume over Value: Decrease in the Average Value of Completed Private Equity Healthcare Deals between 2007 and 2013 24
Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/
For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20